Page 3 - சீனா தடுப்பூசி தொழில் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீனா தடுப்பூசி தொழில் சங்கம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீனா தடுப்பூசி தொழில் சங்கம் Today - Breaking & Trending Today

China approaches record 500m shots administered, likely to 'produce 3b by year-end'


China approaches record 500m shots administered, likely to ‘produce 3b by year-end’
Hu Yuwei and Yu Xi Published: May 23, 2021 09:22 PM
A medical worker administers a dose of the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot to a resident at a temporary vaccination site in Haidian District of Beijing, capital of China, May 20, 2021.Photo:Xinhua
 China is expected to produce more than 3 billion doses by the end of this year and become the first in the world to have administered 500 million shots of COVID-19 vaccines, despite temporary shortages in some places due to booming willingness to take the shots amid the latest domestic cases.    ....

Tao Lina , Feng Duojia , National Health Commission , China Vaccine Industry Association , Haidian District , East China , Northeast China , South China , Guangdong Province , Global Times , தாவோ லினா , தேசிய ஆரோக்கியம் தரகு , சீனா தடுப்பூசி தொழில் சங்கம் , கிழக்கு சீனா , வடகிழக்கு சீனா , தெற்கு சீனா , குவாங்டாங் மாகாணம் , உலகளாவிய முறை ,

Chinese vaccines could fill the gap left by US and India, after WHO approval


file7fokwivj0q9byjr4gak
BEIJING, May 11. Global Times: The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more reliable global vaccine supplier, especially as domestic vaccine producers vowed to ramp up production to meet domestic immunity targets and overseas demand.
After the WHO approved the Sinopharm vaccine for emergency use, Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), said in a recent interview with Chinese media outlets that the Chinese vaccine manufacturer has been ramping up efforts to expand production capacity in the third-phase of production to 3 billion doses per year. ....

New York , United States , United Kingdom , Hala Zayed , Zhuang Shilihe , Feng Duojia , Yang Xiaoming , Hua Chunying , National Health Commission , Egyptian Health , Sinopharm China National Biotec Group , Chinese Foreign Ministry , New York Times , China Vaccine Industry Association , Xinhua News Agency , America First , Health Minister Hala Zayed , Xinhua News , Global Times , Yin Weidong , Cansino Biologic , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஹலா ஸேயெட் , தேசிய ஆரோக்கியம் தரகு ,

China Fills Vaccine Gap Left by US, India to Reach 5 Billion Doses Annually-Dahe.cn - The first brand of local news website in Henan.


Source:
2021-05-11 18:03
The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more reliable global vaccine supplier, especially as domestic vaccine producers vowed to ramp up production to meet domestic immunity targets and overseas demand.
After the WHO approved the Sinopharm vaccine for emergency use, Yang Xiaoming, chairman of Sinopharm China National Biotec Group (CNBG), said in a recent interview with Chinese media outlets that the Chinese vaccine manufacturer has been ramping up efforts to expand production capacity in the third-phase of production to 3 billion doses per year. ....

New York , United States , United Kingdom , Hala Zayed , Zhuang Shilihe , Feng Duojia , Yang Xiaoming , Hua Chunying , National Health Commission , Egyptian Health , Sinopharm China National Biotec Group , Chinese Foreign Ministry , New York Times , China Vaccine Industry Association , Xinhua News Agency , Health Minister Hala Zayed , Xinhua News , Global Times , Yin Weidong , Cansino Biologic , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஹலா ஸேயெட் , தேசிய ஆரோக்கியம் தரகு , எகிப்தியன் ஆரோக்கியம் ,

China fills vaccine gap left by US, India with expanded production to reach 5b doses annually


China fills vaccine gap left by US, India with expanded production to reach 5b doses annually
Global Times reporter on society, cybersecurity, diplomatic relations and topics related to Xinjiang.
Liu Caiyu and Leng Shumei Published: May 10, 2021 10:13 PM Updated: May 11, 2021 10:18 AM
A nurse shows a vial of the Sinopharm vaccine at the Panadura Health Office in Kalutara District, in the outskirts of capital Colombo, Sri Lanka, on May 8, 2021. Sri Lanka s Health Ministry on Saturday began administering the Sinopharm vaccine to local nationals, soon after the World Health Organization (WHO) approved it for emergency use worldwide.(Photo: Xinhua)
The grave epidemic situation in India, the world s largest vaccine producer, the WHO s approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China could be a much more r ....

New York , United States , United Kingdom , World Health Organization , Al Qahirah , Sri Lanka , Hala Zayed , Zhuang Shilihe , Feng Duojia , Yang Xiaoming , Hua Chunying , National Health Commission , Sri Lanka Health Ministry On , Egyptian Health , Sinopharm China National Biotec Group , Chinese Foreign Ministry , New York Times , Panadura Health Office In Kalutara District , China Vaccine Industry Association , Xinhua News Agency , Panadura Health Office , Kalutara District , Health Ministry , America First , Health Minister Hala Zayed , Xinhua News ,